trial · primary record
CR-002
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 219 |
| Primary completion | 2029-01 |
| Primary endpoint | Part 1: Dose Escalation - incidence and nature of dose-limiting toxicities |
| Registry ID | NCT07909031 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:21.205Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07909031
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.